Skip to main content
. 2016 Nov 21;67(2):263–270. doi: 10.1136/gutjnl-2016-312456

Table 1.

Demographics and clinical characteristics of study subjects

Case–control cohorts
Sweden
Italy
US (Mayo)
US (UCLA)
Total
IBS CTRL IBS CTRL IBS CTRL IBS CTRL IBS CTRL
N 387 355 319 255 187 114 138 132 1031 856
Mean age, year 42 42.5 39.6 34.8 47.9 46.6 35.0 33.5 41.4 39.4
% F:M 82:18 43:57 73:27 68:32 91:9 67:33 75:25 58:42 80:20 56:44
IBS-D 127 159 89 42 417
IBS-C 95 128 56 45 324
IBS-M 162 32 41 34 269
IBS-U 3 0 1 17 321
PopCol Total IBS* CTRL* Microbiota Diary
N 250 30 163 136 133
Mean age, year 53.6 51.6 54.7 54.8 54.7
% F:M 64:36 60:40 59:41 62:38 65:35
IBS-D 11
IBS-C 5
IBS-M 9
IBS-U 5

*IBS cases (IBS) and asymptomatic controls (CTRL) were identified based on questionnaire data according to Rome criteria.

Diary, subjects with available daily recordings of defaecation patterns used for correlation analysis with the Val15Phe variant and stool frequency; Microbiota, subjects with available faecal 16S sequencing data; IBS-C, constipation-predominant IBS; IBS-D, diarrhoea-predominant IBS; IBS-M, IBS mixed phenotype; IBS-U, unclassified IBS; PopCol, Population-based Colonoscopy Study; UCLA, University of California, Los Angeles.